The authors concluded that the small evidence base was methodologically compromised, but suggested that risk reduction interventions largely target physical activity and could reduce heart rate and improve exercise capacity and Health Related Quality of Life in people with atrial fibrillation. Given the limitations of the evidence, the authors' suggestion to interpret the results as hypothesis-generating seems appropriate.
Authors' objectives
To determine whether lifestyle and biomedical risk reduction interventions improved outcomes in patients with atrial fibrillation.
Searching
Six databases, including MEDLINE and The Cochrane Library, were searched up to January 2011 for articles in English. Search terms were reported. Reference lists of trials, conference lists, grey literature were searched and keyword internet searching was performed to find additional articles.
Study selection
Eligible for inclusion were randomised controlled trials (RCTs) and quasi-experimental trials that evaluated secondary prevention programmes or lifestyle/biomedical risk reduction interventions in patients with atrial fibrillation. Eligible trials had to be provided by health professionals. Primary outcomes were all-cause mortality, heart rate, exercise capacity and health-related quality of life (HRQoL). Trials that reported solely on pharmacological interventions were excluded.
Included studies were conducted in Canada or Europe. All participants had been diagnosed with chronic atrial fibrillation of at least three months' duration. The mean age of participants ranged from 59 to 68 years, and most were male. Interventions included some form of exercise (usually supervised), such as aerobic or strengthening exercises, and were performed for between 45 and 90 minutes, two to five times per week. Study durations ranged between two months and one year.
Two reviewers independently screened studies for inclusion.
Assessment of study quality
Trial methodology was assessed using the Downs and Black Quality Index Score (maximum score 32). RCTs were also assessed using the Jadad scale.
The authors did not state how many reviewers performed the quality assessments.
Data extraction
Two reviewers independently extracted outcome data. Where outcomes were reported at different time points, the longest follow-up data was used. Primary authors were contacted for further information where necessary.
Methods of synthesis
Data were presented in tables and as a narrative synthesis.
Results of the review
Two RCTs, one retrospective cohort study, and two pre-post studies (166 participants) were included in the review. Trials were reported to be of moderate quality overall; the two RCTs scored 2 or 3 out of 5, and other studies scored between 7 and 16 out of 32. Where reported, the proportion of withdrawals ranged from 0% to 26.3%.
Three trials that assessed heart rate reported reductions in resting heart rate of 7 to 13 beats per minute (bpm) (9 to 15%). All five trials reported an increase in exercise capacity, measured using cycle ergometry (three studies), the six
